Invention Grant
- Patent Title: Anti-cancer gold compounds
-
Application No.: US17595019Application Date: 2020-05-07
-
Publication No.: US12152047B2Publication Date: 2024-11-26
- Inventor: Nedaossadat Mirzadeh , Suresh Bhargava , Steven Priver , Srinivasa Reddy Telukutla
- Applicant: Royal Melbourne Institute of Technology
- Applicant Address: AU Melbourne
- Assignee: Royal Melbourne Institute of Technology
- Current Assignee: Royal Melbourne Institute of Technology
- Current Assignee Address: AU Melbourne
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: AU2019901547 20190507
- International Application: PCT/AU2020/050451 WO 20200507
- International Announcement: WO2020/223765 WO 20201112
- Main IPC: C07F9/53
- IPC: C07F9/53 ; A61P35/00 ; C07F1/02

Abstract:
A compound according to Formula (I), or a pharmaceutically acceptable salt thereof: wherein R1 and R2 are each independently selected from optionally substituted C1-6-alkyl and optionally substituted aryl; R3, R4, R5, and R6 are each independently selected from the group consisting of H, halo, optionally substituted C1-6-alkyl, and optionally substituted C1-6 alkoxy; and R7 is a phosphorus containing moiety, wherein a phosphorus atom is bonded to Au.
Public/Granted literature
- US20220204538A1 ANTI-CANCER GOLD COMPOUNDS Public/Granted day:2022-06-30
Information query